Total Payments
$2,418
2024 Payments
$307.82
Companies
39
Transactions
135
Medicare Patients
18,828
Medicare Billing
$425,127
Payment Breakdown by Category
Food & Beverage$2,405 (99.5%)
Education$12.70 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,405 | 134 | 99.5% |
| Education | $12.70 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $445.76 | 30 | $0 (2024) |
| Allergan, Inc. | $187.40 | 10 | $0 (2020) |
| Gilead Sciences, Inc. | $168.71 | 9 | $0 (2023) |
| Amgen Inc. | $143.90 | 7 | $0 (2024) |
| PFIZER INC. | $143.45 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $126.26 | 7 | $0 (2024) |
| ABBVIE INC. | $126.02 | 7 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $122.97 | 8 | $0 (2023) |
| Astellas Pharma US Inc | $82.14 | 4 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $68.42 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $307.82 | 14 | PFIZER INC. ($85.63) |
| 2023 | $57.04 | 3 | Sumitomo Pharma America, Inc. ($22.40) |
| 2022 | $145.72 | 8 | ABBVIE INC. ($37.40) |
| 2021 | $315.94 | 18 | AbbVie Inc. ($88.62) |
| 2020 | $342.34 | 19 | Allergan, Inc. ($81.64) |
| 2019 | $398.09 | 24 | Merck Sharp & Dohme Corporation ($117.71) |
| 2018 | $484.73 | 29 | Merck Sharp & Dohme Corporation ($164.05) |
| 2017 | $366.50 | 20 | Allergan Inc. ($72.51) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $34.65 | General |
| Category: Oncology | ||||||
| 11/21/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: VACCINES | ||||||
| 11/19/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Cardio-renal | ||||||
| 09/10/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: VACCINES | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: RESPIRATORY | ||||||
| 08/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Cardiology | ||||||
| 08/21/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/28/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Cardiology | ||||||
| 05/21/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: VACCINES | ||||||
| 03/28/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Cardiology | ||||||
| 01/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Inflammation | ||||||
| 01/23/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: VACCINES | ||||||
| 01/18/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/06/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.44 | General |
| 02/28/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: UROLOGY | ||||||
| 01/03/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Gastroenterology | ||||||
| 12/15/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: UROLOGY | ||||||
| 11/01/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: HIV | ||||||
| 10/19/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: NEUROSCIENCE | ||||||
| 05/11/2022 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $16.26 | General |
| Category: Endocrinology | ||||||
| 04/26/2022 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: HIV | ||||||
| 02/22/2022 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: IMMUNOLOGY | ||||||
| 02/02/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 40 | 5,279 | 6,588 | $198,602 | $105,422 |
| 2022 | 43 | 4,484 | 5,540 | $179,543 | $101,975 |
| 2021 | 37 | 4,132 | 5,454 | $180,723 | $102,257 |
| 2020 | 37 | 4,933 | 6,037 | $243,742 | $115,473 |
Total Patients
18,828
Total Services
23,619
Medicare Billing
$425,127
Procedure Codes
157
All Medicare Procedures & Services
157 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 127 | 204 | $49,664 | $12,274 | 24.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 114 | 158 | $28,780 | $6,339 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 80 | $27,614 | $6,318 | 22.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 278 | 371 | $6,233 | $6,107 | 98.0% |
| 83519 | Measurement of substance using immunoassay technique, by radioimmunoassay | Office | 2023 | 263 | 311 | $5,722 | $5,607 | 98.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 304 | 525 | $5,613 | $5,434 | 96.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 74 | 74 | $5,176 | $5,072 | 98.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 272 | 367 | $4,914 | $4,815 | 98.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 296 | 517 | $4,469 | $4,299 | 96.2% |
| 82306 | Vitamin d-3 level | Office | 2023 | 125 | 144 | $4,262 | $4,177 | 98.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 302 | 461 | $3,632 | $3,508 | 96.6% |
| 87631 | Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | Office | 2023 | 20 | 23 | $4,954 | $3,215 | 64.9% |
| 82172 | Apolipoprotein level | Office | 2023 | 220 | 226 | $3,236 | $3,171 | 98.0% |
| 83695 | Lipoprotein (a) level | Office | 2023 | 217 | 222 | $4,682 | $3,115 | 66.5% |
| 86141 | Measurement c-reactive protein for detection of infection or inflammation, high sensitivity | Office | 2023 | 214 | 229 | $2,970 | $2,906 | 97.8% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 270 | 330 | $2,977 | $2,897 | 97.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 74 | 74 | $2,383 | $2,335 | 98.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 131 | 140 | $2,111 | $2,069 | 98.0% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 72 | 75 | $2,754 | $1,897 | 68.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 183 | 209 | $3,458 | $1,868 | 54.0% |
| 82746 | Folic acid level, serum | Office | 2023 | 126 | 129 | $1,896 | $1,859 | 98.0% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 133 | 135 | $1,840 | $1,804 | 98.0% |
| 84152 | Psa (prostate specific antigen) measurement, complexed | Office | 2023 | 74 | 95 | $1,747 | $1,712 | 98.0% |
| 82977 | Glutamyltransferase (liver enzyme) level | Office | 2023 | 209 | 218 | $1,570 | $1,539 | 98.1% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2023 | 194 | 241 | $1,569 | $1,538 | 98.0% |
About Dr. David Dodson, M.D
Dr. David Dodson, M.D is a Infectious Disease healthcare provider based in West Palm Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265460307.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Dodson, M.D has received a total of $2,418 in payments from pharmaceutical and medical device companies, with $307.82 received in 2024. These payments were reported across 135 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($2,405).
As a Medicare-enrolled provider, Dodson has provided services to 18,828 Medicare beneficiaries, totaling 23,619 services with total Medicare billing of $425,127. Data is available for 4 years (2020–2023), covering 157 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location West Palm Beach, FL
- Active Since 06/29/2006
- Last Updated 10/07/2011
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1265460307
Products in Payments
- ZERBAXA (Drug) $251.78
- XIFAXAN (Drug) $140.44
- UBRELVY (Drug) $111.67
- Repatha (Biological) $109.30
- PREVNAR 20 (Biological) $85.63
- CRESEMBA (Drug) $82.14
- DIFICID (Drug) $80.14
- VIBERZI (Drug) $72.51
- ENTRESTO (Drug) $68.42
- AVYCAZ (Drug) $62.24
- Arikayce (Drug) $57.32
- GEMTESA (Drug) $44.30
- XERAVA (Drug) $40.80
- PRALUENT (Drug) $40.32
- QULIPTA (Drug) $39.71
- SHINGRIX (Biological) $38.68
- Dayvigo (Drug) $37.10
- Livalo (Drug) $36.81
- Cologuard Collection Kit (Device) $34.65
- Otezla (Drug) $34.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in West Palm Beach
Dr. Olayemi Osiyemi, Md, MD
Infectious Disease — Payments: $396,544
Infectious Disease $396,544
Jose Menajovsky, Md, MD
Infectious Disease — Payments: $19,470
Infectious Disease $19,470
George Carden, M.d, M.D
Infectious Disease — Payments: $2,355
Infectious Disease $2,355
James Morris, M.d, M.D
Infectious Disease — Payments: $122.41
Infectious Disease $122.41
Thomas Parrino, M.d, M.D
Infectious Disease
Infectious Disease